SCHEMBL5428893

SCHEMBL5428893

C=C(C)C(=O)OCC(F)(F)F.C=C(CC=CC(=O)O)C(=O)OC

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid Methyl Ester SCHEMBL645362 0.93 ALDH1A1 (0.31) ALDH1A1
SCHEMBL1473949 0.84 ALDH1A1 (0.52) ALDH1A1TSHR
Methacrylic Acid SCHEMBL1219401 0.81 ALDH1A1 (0.42) ALDH1A1TSHR
SCHEMBL239948 0.81 HCAR2 (0.40) ALDH1A1TSHR
Acrylic Acid SCHEMBL1475104 0.80 ALDH1A1 (0.47) ALDH1A1TSHR
SCHEMBL5327081 0.80 TSHR (0.57) ALDH1A1TSHR
SCHEMBL6737151 0.80 ALDH1A1 (0.58) ALDH1A1TSHR
SCHEMBL8678429 0.78 ALDH1A1 (0.44) ALDH1A1TSHR
SCHEMBL3400634 0.77 TSHR (0.60) ALDH1A1TSHR
Butadiene SCHEMBL11340927 0.77 HCAR2 (0.36) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070166259-A1 Cosmetic composition comprising a tensioning agent and a particular block ethylenic polymer L'OREAL (FR) 2007-07-19 US claimed
US-20070166259-A1 Cosmetic composition comprising a tensioning agent and a particular block ethylenic polymer L'OREAL (FR) 2007-07-19 US disclosed
EP-1675558-A1 COSMETIC COMPOSITION COMPRISING A TENSIONING AGENT AND A PARTICULAR BLOCK ETHYLENIC POLYMER L'OREAL (FR) 2006-07-05 EP disclosed
WO-2005030158-A1 COSMETIC COMPOSITION COMPRISING A TENSIONING AGENT AND A PARTICULAR BLOCK ETHYLENIC POLYMER L'OREAL (FR) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070166259-A1 Cosmetic composition comprising a tensioning agent and a particular block ethylenic polymer CUTA, ERCC1, RAD23B ALDH1A1 4511/4885TSHR 4004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.